» Articles » PMID: 30509113

Morphological and Immunohistochemical Biomarkers in Distinguishing Prostate Carcinoma and Urothelial Carcinoma: A Comprehensive Review

Overview
Publisher Sage Publications
Date 2018 Dec 5
PMID 30509113
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The differential diagnosis between high-grade prostate carcinoma and infiltrating urothelial carcinoma (UC) in transurethral resection prostate specimens as well as cystoprostatectomy specimens may often be challenging due to morphologic and clinical overlap of the 2 entities. Such distinction has critical therapeutic and staging consequences, yet it is hampered by both issues in morphology and by the low accuracy rates of single immunohistochemical markers, as reported in literature. This review aims to provide a comprehensive analysis of the available morphological and immunohistochemical parameters, which may allow to discriminate between prostate carcinoma and urothelial carcinoma in the proper clinical context and to discuss their diagnostic applications in daily practice.

Citing Articles

Prognostic Value of P63 Expression in Muscle-Invasive Bladder Cancer and Association with Molecular Subtypes-Preliminary Report.

Sanguedolce F, Falagario U, Zanelli M, Palicelli A, Zizzo M, Ascani S Curr Issues Mol Biol. 2024; 46(3):2456-2467.

PMID: 38534771 PMC: 10968749. DOI: 10.3390/cimb46030155.


Nephrogenic Adenoma of the Prostatic Urethra Mimicking Prostatic and Bladder Carcinomas.

Beeter M, Fazili T, Yeh Y Cureus. 2023; 15(3):e35998.

PMID: 37041930 PMC: 10083124. DOI: 10.7759/cureus.35998.


Accurate Characterization of Bladder Cancer Cells with Intraoperative Flow Cytometry.

Paliouras A, Markopoulos G, Tsampalas S, Mantziou S, Giannakis I, Baltogiannis D Cancers (Basel). 2022; 14(21).

PMID: 36358858 PMC: 9656620. DOI: 10.3390/cancers14215440.


Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 1: General Issues and Marker Expression.

Sanguedolce F, Zanelli M, Palicelli A, Ascani S, Zizzo M, Cocco G Int J Mol Sci. 2022; 23(14).

PMID: 35887164 PMC: 9319819. DOI: 10.3390/ijms23147819.


Identification of a Nuclear Mitochondrial-Related Multi-Genes Signature to Predict the Prognosis of Bladder Cancer.

Jiang X, Xia Y, Meng H, Liu Y, Cui J, Huang H Front Oncol. 2021; 11:746029.

PMID: 34692528 PMC: 8528313. DOI: 10.3389/fonc.2021.746029.